Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Ghasoub Rola, Maria Benkhadra, Anas Hamad, Randa AlOkka, Ruba Yasin Taha, Honar Cherif, Safaa Alazawi, Mohammad Bakir, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7128.

https://doi.org/10.1182/blood-2025-7128

Published: 2025

Journal Articles

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7264.

https://doi.org/10.1182/blood-2025-7264

Published: 2025

Journal Articles

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

Ghasoub Rola, Maria Benkhadra, Anas Hamad, Mohammad Bakir, Hesham Elsabah, Layali Bakir, Rajvir Singh, Honar Cherif, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 6348.

https://doi.org/10.1182/blood-2025-6348

Published: 2025

Journal Articles

Experience of Plerixafor Use for Autologous Stem Cell Mobilization in Qatar: A Single Center Experience

Amaal Gulied, Farah Imadeldeen Jibril, Rola Ghasoub, Aya Alasmar, Yahya Mulikandathil, Afraa Mustafa Sulieman Fadul, Amna Gameil, Manal Yaghmour, Wedad Saleem, Fabio Culurgioni, Saloua Hmissi, Shereen Elazzazy, Anas Ahmad Hamad, Javid Gaziev, Mohammad Bakr

Blood (2024) 144 (Supplement 1): 7123.

https://doi.org/10.1182/blood-2024-212076

Published: 2024

Journal Articles

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Rola Ghasoub, Shereen Elazzazy, Maria Benkhadra, Nancy Kassem, Honar Cherif, Javid Gaziev, Hesham Elsabah, Anas Ahmad Hamad

Blood (2023) 142 (Supplement 1): 5079.

https://doi.org/10.1182/blood-2023-185615

Published: 2023

Journal Articles

Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

Maria Benkhadra, Shereen Elazzazy, Anas Ahmad Hamad, Mohamed S. Elkhatim, Amaal Gulied, Arwa Osama Sahal, Aya Alasmar, Farah I. Jibril, Hebatalla Mahmoud Afifi, Sahar Nasser, Afnan Alnajjar, Rawan Dawoud, Nabil E. Omar

Blood (2023) 142 (Supplement 1): 5378.

https://doi.org/10.1182/blood-2023-180648

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

Experience of Plerixafor Use for Autologous Stem Cell Mobilization in Qatar: A Single Center Experience

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

Email alerts

ASH Publications

American Society of Hematology

Update search

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

Experience of Plerixafor Use for Autologous Stem Cell Mobilization in Qatar: A Single Center Experience

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only